Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-14-000028
Filing Date
2014-01-22
Accepted
2014-01-22 21:29:27
Documents
1
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3179
  Complete submission text file 0001250853-14-000028.txt   4847
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 310 N. STATE STREET, SUITE 208 LAKE OSWEGO OR 97034
Business Address
Dunlap Ryan (Reporting) CIK: 0001554742 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 14541449